![Page 1: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/1.jpg)
to an Exceptional Eczema Experience
Richard J. Antaya, MD, FAAP, FAAD
Professor of Dermatology and Pediatrics
Director, Pediatric Dermatology
Yale University School of Medicine
New Haven, CT
The 5 E ’s
![Page 2: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/2.jpg)
Potential Conflict of Interest Disclosure
Astellas Research
local PI for APPLES registry for long term safety evaluation of Protopic
1
![Page 3: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/3.jpg)
Impact of Atopic Dermatitis
• prevalence -- 10-17% of all children* • mild in 85%• mod to severe -- profound effect on QOL
– intractable itching and sleep loss– soreness, scarring, dyspigmentation– messy topicals– social stigma– QOL impairment equivalent to CF– costs more than childhood diabetes
• 4% of adults with persistent disease• 40-60% continue to experience disease intermittent exacerbations
*adapted from Laughter D. J Am Acad Dermatol 2000; 43:649-55.2
![Page 4: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/4.jpg)
Diagnosis of Atopic DermatitisDiagnostic Criteria
• Pruritus • Eczema (from Greek - to boil, to erupt)
– chronic & recurring• acute• chronic• subacute
Adapted from Hanifin, Rajka. Acta Dermato Venereol. 92(suppl):44-7;1980 and AAD Consensus Conference on Pediatric Atopic Dermatitis
3
![Page 5: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/5.jpg)
Atopic DermatitisClinical Presentation
• 6 skin findings of eczema1. erythema
2. papules/edema
3. exudation - oozing and crusting
4. scale
5. excoriations linear erosions from scratching
6. Lichenification thickened, hyperpigmented, leathery skin due to
rubbing (accentuated skin markings)
• symmetric > asymmetric
4
![Page 6: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/6.jpg)
Diagnosis of Atopic DermatitisDiagnostic Criteria
• Pruritus • Eczema (from Greek - to boil, to erupt)
– chronic & recurring• acute• chronic• subacute
– age-specific distribution
Adapted from Hanifin, Rajka. Acta Dermato Venereol. 92(suppl):44-7;1980 and AAD Consensus Conference on Pediatric Atopic Dermatitis
6
![Page 7: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/7.jpg)
ATOPIC DERMATITIS Infantile Distribution
• face - cheeks and chin• “head light” sign – mid-facial sparing• extensor extremities, dorsal hands and feet• very rarely on palms or soles • can have widespread involvement• diaper area often spared• pruritus
7
![Page 8: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/8.jpg)
8
![Page 9: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/9.jpg)
ATOPIC DERMATITISChildhood-Adult Distribution
• antecubital and popliteal fossae• posterior neck• presacral back, buttocks, flanks• eyelids• scalp• hands, feet palms and soles• may be severe and generalized• “head light” sign
9
![Page 10: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/10.jpg)
11
![Page 11: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/11.jpg)
12
![Page 12: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/12.jpg)
Diagnosis of Atopic DermatitisAssociated Features
• early age at onset – 80-90% by 5 years
• personal or family history of atopy• xerosis
– associated with ichthyosis vulgaris (IV)– worse prognosis in patients with IV
13
![Page 13: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/13.jpg)
Complications of AD
16
![Page 14: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/14.jpg)
Eczema Herpeticum
17
![Page 15: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/15.jpg)
17
![Page 16: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/16.jpg)
19
![Page 17: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/17.jpg)
EczemaVaccinatum
20
![Page 18: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/18.jpg)
Impetigo
21
![Page 19: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/19.jpg)
S. aureus and Atopic Dermatitis Endogenous Antimicrobial Peptides
• antimicrobial peptides in the skin– cathelicidins– human -defensin-2 (HBD-2)
• accumulate in response to skin inflammation• normal levels in psoriasis lesions• decreased levels in lesions
– AD, eczema herpeticum, eczema vaccinatum
• IL-4 and IL-13 inhibit HBD-2 production
Adapted from Ong P. N Engl J Med. 347(15), Oct 10, 2002 1151-60 22
![Page 20: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/20.jpg)
Treatment Approach
27
![Page 21: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/21.jpg)
ATOPIC DERMATITIS5 E’s to an Exceptional Eczema Experience
1. Education - level of success is directly related to how much education patients and their families receive about AD*
2. Expectations – Endpoints– Clearance vs Maintenance phases of therapy
3. Encouragement
4. Enough medication – campfire analogy
5. Early return visit (2 weeks)
*Staab, D. BMJ 332:933-938.28
![Page 22: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/22.jpg)
Clinical Approach to Atopic DermatitisMy Spiel
Educate• Explain what it is and what it is not
– No cure, not a single allergy, but can be controlled– “The itch that rashes”– Alloknesis (cutaneous hyperaesthesia)*
• perceive normally “nonitchy” stimuli as “itchy”
• Explain the provokers of itch in A.D.– heat and perspiration 96%– wool 91%– emotional stress 81%– certain foods (rarely)– “common cold” 36%
*Hagermark O. in Bernhard JD. Pruritus in skin disease. McGraw-Hill, 1994 pp37-6729
![Page 23: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/23.jpg)
Clinical Approach to Atopic DermatitisMy Spiel
• Expectations – Endpoints– Clearance with anti-inflammatory meds – Maintenance with trigger avoidance and
moisturization
• Explain rationale for proposed therapy– Enough medicine -- Campfire analogy
30
![Page 24: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/24.jpg)
ATOPIC DERMATITIS The Spiel on General Skin Care
soaps• avoid “true soaps”
– Dial, Ivory, Irish Spring
• moisturizing cleansers– Dove, Tone, Olay Complete
• soap free cleansers– Cetaphil, Aquanil
• avoid entirely during flares
31
![Page 25: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/25.jpg)
Nice &
Smooth
Not nice,Rough
& Yucky
32
![Page 26: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/26.jpg)
ATOPIC DERMATITIS The Spiel on General Skin Care
moisturizers• immediately after bathing and prn (multiple
times/day)• avoid lotions; use creams and ointments• Eucerin, Aquaphor, petrolatum, Cetaphil, Acid
Mantle cream, Vanicream, Theraplex Emollient• Ceremide-based – Epiceram, CeraVe, Cetaphil
Restoraderm
33
![Page 27: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/27.jpg)
ATOPIC DERMATITISThe Spiel on General Skin Care
– laundry detergents • hypoallergenic detergents• Dreft, Ivory Snow
– avoid• dryer sheets and fabric softeners• wool and polyester fabrics• extremes of temperature, humidity• dust mites (mattress, box spring, pillow covers)
• Certain foods – milk, wheat, egg, soy
34
![Page 28: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/28.jpg)
ATOPIC DERMATITIS Hanifin’s Truisms of Bathing
“Bathing dries the skin”
A: True
If skin allowed to air dry.
“Bathing hydrates the skin”
A: True
If moisturizer is applied immediately after.
No conclusive data supported by studies35
![Page 29: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/29.jpg)
ATOPIC DERMATITIS Bathing Recommendations
• showers - o.k. if not flaring• bath - if more severe b.i.d. for 10 min, tepid• do not rub, scrub or use washcloths• pat dry partially with a towel - don’t rub• within 3 minutes apply moisturizer and/or
topical medication
36
![Page 30: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/30.jpg)
ATOPIC DERMATITISMEDICAL TREATMENT
weak topical corticosteroids non-fluorinated ointments or creams
Hydrocortisone acetate 0.5, 1.0, or 2.5% Hydrocortisone valerate 0.2% Desonide, fluticasone lotion/cr (low), aclometasone
medium to high potency steroids Triamcinolone (med) Fluticasone ointment (med) Mometasone cream (med) mometasone ointment (high)
38
![Page 31: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/31.jpg)
Topical Steroid Monotherapy Regimen
• Standard regimen– Twice daily for 2 weeks (esp. first treatment)– Then p.r.n. based on need and response to Rx
• More severe regimen Pulse dose (once or twice) on weekends 3 consecutive days/week
Most severe regimen Single application 3 days/week during maintenance phase
Mon, Wed, and Fri Decreases frequency of flares
39
![Page 32: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/32.jpg)
Enough Medication
• Frequency• Duration• Recommended amount per dose
– adult hand = ~ 0.5 gm– total BSA of 3-6 mo = 4-5 gm – total BSA of 6-10 yo = 10 gm– total BSA of an adult = 20-30 gm
• Topical meds dispensed as – 15, 30, 45, 60, 80 or 100 gram tubes– 1 lb (454 gm) jars
40
![Page 33: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/33.jpg)
Enough Medication
ESTIMATES FOR QUICK MEMORIZATION • Recommended amount per dose
– total BSA of a 5 mo = 5 gm – total BSA of a 5-10 yo = 10 gm– total BSA of a 20 yo = 20 gm
• Do the math…– 5 m.o. 100% BSA = 5gm x 2 = 10gm x 14 days = 140 gm– 7 y.o. 100% BSA = 10gm x 2 = 20gm x 14 days = 280 gm
41
![Page 34: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/34.jpg)
Enough MedicationOnly topical steroids sold in 1 lb jars
– triamcinolone acetonide – hydrocortisone acetate
x 16 =30 gram tube
1 lb (454 gm) jar
42
![Page 35: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/35.jpg)
Clinical Approach to Atopic DermatitisCampfire Analogy
v
v
43
![Page 36: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/36.jpg)
“Soak and Smear” of Topical Steroids
• Soak and Smear regimen – Soak in a bath with plain water (no soap) for 10
min at night (or b.i.d.)– Then smear on the topical steroid (usually
triamcinolone 0.1% ointment) immediately without drying
– After skin is improved stop soaks but continue the topical steroid at night
Gutman AB, Kligman AM, Sciacca J, James WD. Arch Dermatol Dec 2005;141:1556-59
45
![Page 37: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/37.jpg)
STEROID-INDUCED ATROPHY
50
![Page 38: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/38.jpg)
STRIAE DISTENSAE mometasone ointment x several months in a teen
51
![Page 39: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/39.jpg)
Topical Calcineurin Inhibitors (TCI’s)Protopic Ointment (tacrolimus)
Elidel Cream (pimecrolimus)
Proposed mechanism of action– CD4+ lymphocytes– inhibits calcineurin– inhibits gene transcription
• IL-2, IL-3, IL-4, IL-5, GM-CSF, TNF-, IFN-
52
![Page 40: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/40.jpg)
Tacrolimus 0.1% Open label Phase III b Study: Baseline
53
![Page 41: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/41.jpg)
Tacrolimus 0.1% Open label Phase III b Study: Month 9
54
![Page 42: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/42.jpg)
Pimecrolimus Treatment of Atopic Dermatitis
Baseline
3 weeks
55
![Page 43: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/43.jpg)
When do I use the TCI’s?
• Concerns about steroid use– Can’t get off topical steroid– Using steroids too frequently or continuously– Location too risky
• Intertriginous areas• Eyelids
• Steroids ineffective• Discuss FDA boxed warning
56
![Page 44: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/44.jpg)
ATOPIC DERMATITISADJUNCTIVE ANTIBIOTICS/ANTIBACTERIALS
• Treat impetigo/ superinfection – oral antibiotics
• Reduce S aureus topically– N3 (Nose, Nails, Navel) mupirocin b.i.d. 5 days/mo– Bleach baths*
• 4 oz/ ~25 gal (tubful) water or ~2 tsp/gal H2O
• 3 times weekly - daily • Clinically proven to improve eczema scores in patients who
previously had AD-associated impetigo
Huang JT et al, Pediatrics. 123(5):e808-14, 2009 MayHuang JT, Rademaker A, Paller AS. Arch Dermatol. 147(2):246-7, 2011 Feb.
57
![Page 45: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/45.jpg)
ATOPIC DERMATITISANTIHISTAMINES
• especially hs– hydroxyzine (Atarax)– diphenhydramine (Benadryl)– cyproheptadine (Periactin)– doxepin (Sinequan) – cardiotoxic !
• randomized trials have not demonstrated improvement with sedating or non-sedating antihistamines
58
![Page 46: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/46.jpg)
AD Habit-Reversal Techniques (HRT)Breaking the itch-scratch cycle
Scratching
Epidermal Damage
Increased Adhesin Exposure collagen, fibronectin, fibrinogen
Increased S. aureus binding/ inflammation
pruritus
59
![Page 47: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/47.jpg)
AD Habit-Reversal Techniques (HRT)
• Effective for tics and nervous habits • Scratching is maintained by operant reinforcement• HRT teaches
– recognize the habit– identify situations that provoke it– train to develop a “competing response practice”– Striking, patting, or grasping the area
• Requires a motivated patient and physician
60
![Page 48: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/48.jpg)
Atopic Dermatitis Therapeutic Pyramid
Protective Skin Care & Trigger Avoidance
Topical Steroids
Anti-Staph AntibioticsAntihistamines
Topical Calcineurin Inhibitors
UV Phototherapy
Systemic Immunomodulators
Allergy Testing/AvoidanceHabit Reversal
61
![Page 49: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/49.jpg)
ATOPIC DERMATITIS5 E’s to an Exceptional Eczema Experience
1. Education
2. Expectations 1. Endpoints
2. Clearance vs Maintenance
3. Encouragement
4. Enough medication – campfire analogy
5. Early return visit (2 weeks)
62
![Page 50: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/50.jpg)
Thanks for your attention!
63
![Page 51: To an Exceptional Eczema Experience Richard J. Antaya, MD, FAAP, FAAD Professor of Dermatology and Pediatrics Director, Pediatric Dermatology Yale University](https://reader038.vdocuments.us/reader038/viewer/2022103004/56649ca35503460f94962f3b/html5/thumbnails/51.jpg)
Cure sometimes
Relieve often
Comfort always
64